Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Do tardive dyskinesia and L-dopa induced dyskinesia share common genetic risk factors? An exploratory study.

Journal of molecular neuroscience : MN - 1 Oct 2013

Greenbaum Lior, Goldwurm Stefano, Zozulinsky Polina, Lifschytz Tzuri, Cohen Oren S, Yahalom Gilad, Cilia Roberto, Tesei Silvana, Asselta Rosanna, Inzelberg Rivka, Kohn Yoav, Hassin-Baer Sharon, Lerer Bernard

Abstract excerpt

Tardive dyskinesia (TD) in schizophrenia patients treated with antipsychotic medications and L-dopa induced dyskinesia (LID) among Parkinson's disease (PD) affected individuals share similar clinical features. Both conditions are induced by chronic exposure to drugs that target dopaminergic receptors (antagonists in TD and agonists in LID) and cause pulsatile and nonphysiological stimulation of these receptors....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dyskinesia, Drug-Induced

Share to Israel

Share to Levodopa

Share to Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 23666822
DOI: 10.1007/s12031-013-0020-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Do tardive dyskinesia and L-dopa induced dyskinesia share common genetic risk factors? An exploratory study.PMID 23666822Read ↗

Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s diseaseSemantic proximity Read ↗

Dopamine pathway and Parkinson’s risk variants are associated with levodopa-induced dyskinesiaSemantic proximity Read ↗

Candidate Genes Encoding Dopamine Receptors as Predictors of the Risk of Antipsychotic-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenic PatientsSemantic proximity Read ↗

Genetic Factors Associated With Tardive Dyskinesia: From Pre-clinical Models to Clinical StudiesSemantic proximity Read ↗

Genetic underpinnings of tardive dyskinesia: passing the baton to pharmacogenetics.Semantic proximity Read ↗

Epidemiology and risk factors for (tardive) dyskinesia.Semantic proximity Read ↗

Pharmacogenetic profile and the development of the dyskinesia induced by levodopa-therapy in Parkinson's disease patients: a population-based cohort study.Semantic proximity Read ↗

Genetics of tardive dyskinesia: a review of progress over the past decade.Semantic proximity Read ↗

Sequence variants in SLC6A3, DRD2, and BDNF genes and time to levodopa-induced dyskinesias in Parkinson's disease.Semantic proximity Read ↗

Candidate gene-based association study of antipsychotic-induced movement disorders in long-stay psychiatric patients: a prospective study.Semantic proximity Read ↗

Pharmacogenetics of tardive dyskinesia: an updated review of the literature.Semantic proximity Read ↗

Dopamine genetic risk scores and psychiatric symptoms: Interacting risk factors for impulse control behaviours in de novo Parkinson's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.